Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Read more
FDA Approved Utidelone Injectable (UTD1) Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer Read more
Sandoz introduces Act4Biosimilars Action Plan to accelerate patient access to biosimilar medicines Read more
Soliris approved in China for the treatment of adults with refractory generalised myasthenia gravis Read more
DTx Pharma Receives FDA Orphan Drug Designation for DTx-1252 for the Treatment of Charcot-Marie-Tooth Disease Type 1A (CMT1A) Read more
Andexxa Phase IV trial stopped early after achieving pre-specified criteria on haemostatic efficacy versus usual care Read more
INJECTAFER Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure Read more